A new mechanism for the actions of olanzapine.
Li
X M
XM
Juorio
A V
AV
Chlan-Fourney
J
J
Shrikhande
S
S
Bennett
V L
VL
Keegan
D L
DL
D014150:Antipsychotic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001569:Benzodiazepines; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D018696:Neuroprotective Agents / Q000494:pharmacology*; D000077152:Olanzapine; D016761:Oncogene Proteins v-fos / Q000187:drug effects; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000494:pharmacology; D012333:RNA, Messenger / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy; D013482:Superoxide Dismutase / Q000235:genetics / Q000378:metabolism; D015854:Up-Regulation / Q000187:drug effects
D014150:Antipsychotic Agents; D018696:Neuroprotective Agents; D016761:Oncogene Proteins v-fos; D012333:RNA, Messenger; D001569:Benzodiazepines; D010890:Pirenzepine; D013482:Superoxide Dismutase; D000077152:Olanzapine